InvestorsHub Logo

renovatio33

11/08/17 11:07 AM

#61793 RE: glg20 #61792

We still need near-term news on the following items:

Strasbourg placement and initial feedback

Columbia feedback (academic institution so will absolutely take longer than Nicholson). Keep in mind that Columbia received an advanced prototype, so we could be hearing some very exciting things once we do.

Like Flenderson said, I assume this (Monday) will be a general update across the board. All ducks are in a row and I think they (McNally) simply want to remove some of the uncertainty that keeps share price somewhat bottled.

They won't announce design freeze until trials are through. Assuming no major changes and an efficient documentation process for submission, we should be well ahead on timing.

QuidWilson

11/08/17 11:45 AM

#61796 RE: glg20 #61792

Wonder if this little nugget is in play?...

Titan Medical Inc.'s analysts see 300.00% EPS growth.



But, this article confuses me, not sure if it's credible...

http://expressnewsline.com/2017/11/07/the-priceline-group-inc-pcln-releases-q4-earnings-guidance.html